S A Glasmacher1, P Bonongwe2, W Stones3. 1. School of Medicine University of St Andrews United Kingdom. 2. Department of Obstetrics and Gynaecology, Queen Elizabeth Central Hospital, Blantyre, Malawi. 3. School of Medicine University of St Andrews United Kingdom; Department of Obstetrics and Gynaecology, College of Medicine, University of Malawi, Blantyre, Malawi; School of Public Health and Family Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
Abstract
BACKGROUND: To achieve good outcomes in critically ill obstetric patients, it is necessary to identify organ dysfunction rapidly so that life-saving interventions can be appropriately commenced. However, timely access to clinical chemistry results is problematic, even in referral institutions, in the sub-Saharan African region. Reliable point-of-care tests licensed for clinical use are now available for lactate and creatinine. AIM: We aimed to assess whether implementation of point-of-care testing for lactate and creatinine is feasible in the obstetric unit at the Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi, by obtaining the opinions of clinical staff on the use of these tests in practice. METHODS: During a two-month evaluation period nurse-midwives, medical interns, clinical officers, registrars, and consultants were given the opportunity to use StatStrip® and StatSensor® (Nova Biomedical, Waltham, USA) devices, for lactate and creatinine estimation, as part of their routine clinical practice in the obstetric unit. They were subsequently asked to complete a short questionnaire. RESULTS: Thirty-seven questionnaires were returned by participants: 22 from nurse-midwives and the remainder from clinicians. The mean satisfaction score for the devices was 7.6/10 amongst clinicians and 8.0/10 amongst nurse-midwives. The majority of participants stated that the obstetric high dependency unit (HDU) was the most suitable location for the devices. For lactate, 31 participants strongly agreed that testing should be continued and 24 strongly agreed that it would influence patient management. For creatinine, 29 strongly agreed that testing should be continued and 28 strongly agreed that it would influence their patient management. Twenty participants strongly agreed that they trust point-of-care devices. CONCLUSIONS: Point-of-care clinical chemistry testing was feasible, practical, and well received by staff, and was considered to have a useful role to play in the clinical care of sick obstetric patients at this referral centre.
BACKGROUND: To achieve good outcomes in critically ill obstetricpatients, it is necessary to identify organ dysfunction rapidly so that life-saving interventions can be appropriately commenced. However, timely access to clinical chemistry results is problematic, even in referral institutions, in the sub-Saharan African region. Reliable point-of-care tests licensed for clinical use are now available for lactate and creatinine. AIM: We aimed to assess whether implementation of point-of-care testing for lactate and creatinine is feasible in the obstetric unit at the Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi, by obtaining the opinions of clinical staff on the use of these tests in practice. METHODS: During a two-month evaluation period nurse-midwives, medical interns, clinical officers, registrars, and consultants were given the opportunity to use StatStrip® and StatSensor® (Nova Biomedical, Waltham, USA) devices, for lactate and creatinine estimation, as part of their routine clinical practice in the obstetric unit. They were subsequently asked to complete a short questionnaire. RESULTS: Thirty-seven questionnaires were returned by participants: 22 from nurse-midwives and the remainder from clinicians. The mean satisfaction score for the devices was 7.6/10 amongst clinicians and 8.0/10 amongst nurse-midwives. The majority of participants stated that the obstetric high dependency unit (HDU) was the most suitable location for the devices. For lactate, 31 participants strongly agreed that testing should be continued and 24 strongly agreed that it would influence patient management. For creatinine, 29 strongly agreed that testing should be continued and 28 strongly agreed that it would influence their patient management. Twenty participants strongly agreed that they trust point-of-care devices. CONCLUSIONS: Point-of-care clinical chemistry testing was feasible, practical, and well received by staff, and was considered to have a useful role to play in the clinical care of sick obstetric patients at this referral centre.
Authors: Tim C Jansen; Jasper van Bommel; F Jeanette Schoonderbeek; Steven J Sleeswijk Visser; Johan M van der Klooster; Alex P Lima; Sten P Willemsen; Jan Bakker Journal: Am J Respir Crit Care Med Date: 2010-05-12 Impact factor: 21.405
Authors: Christopher C Moore; Shevin T Jacob; Relana Pinkerton; David B Meya; Harriet Mayanja-Kizza; Steven J Reynolds; W Michael Scheld Journal: Clin Infect Dis Date: 2008-01-15 Impact factor: 9.079
Authors: Simran Sharma; Summia Zaher; Patrícia R S Rodrigues; Luke C Davies; Sarah Edkins; Angela Strang; Mallinath Chakraborty; W John Watkins; Robert Andrews; Edward Parkinson; Nicos Angelopoulos; Linda Moet; Freya Shepherd; Kate Megan Megan Davies; Daniel White; Shaun Oram; Kate Siddall; Vikki Keeping; Kathryn Simpson; Federica Faggian; Maryanne Bray; Claire Bertorelli; Sarah Bell; Rachel E Collis; James E McLaren; Mario Labeta; Valerie B O'Donnell; Peter Ghazal Journal: BMJ Open Date: 2022-09-17 Impact factor: 3.006
Authors: Uwezo Edward; Hendry R Sawe; Juma A Mfinanga; Theresia A Ottaru; Michael Kiremeji; Deus N Kitapondya; Dereck A Kaale; Asha Iyullu; Nicks Bret; Ellen J Weber Journal: Trop Med Health Date: 2019-12-27